Literature DB >> 3326634

Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.

A H van den Meiracker1, A J Man in't Veld, M A Schalekamp.   

Abstract

1. Haemodynamic changes during the onset of the antihypertensive action of pindolol, 10 mg twice daily, and propranolol, 80 mg three times daily, were studied for 24 h in two groups of 10 patients with uncomplicated essential hypertension. 2. Baseline haemodynamics were not different between the two groups. 3. Pindolol, with considerable intrinsic sympathomimetic activity (ISA) exerted its maximal antihypertensive efficacy within 3-4 after dosing (-15 +/- 3%, mean +/- s.e. mean, P less than 0.001). This effect was maintained for 24 h. 4. After propranolol, which is devoid of ISA, arterial pressure fell more gradually, but after 24 h the two drugs shared an equal antihypertensive effect. 5. Cardiac output rose after pindolol by 16 +/- 5% (P less than 0.01). It decreased transiently by 16 +/- 6% (P less than 0.01) 1-4 h after propranolol. At that time vascular resistance had risen by 18 +/- 5% (P less than 0.001). 6. The onset of the antihypertensive action of the two drugs was associated with reductions in vascular resistance. Since reflex vasoconstriction did not occur after pindolol, vascular resistance was always lower on this drug than on propranolol (-29 +/- 4%, P less than 0.001 vs -15 +/- 5%, P less than 0.01). 7. Cardiac filling pressures, pulmonary artery pressure and pulmonary vascular resistance did not change after pindolol but they rose after propranolol. 8. During the onset of the vasodilator and antihypertensive effects of the two beta-adrenoceptor blockers heart rate, stroke volume and cardiac output rose, despite cardiac beta-adrenoceptor blockade, suggesting a reduction of parasympathetic tone and an increase in venous return.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326634      PMCID: PMC1386207          DOI: 10.1111/j.1365-2125.1987.tb03267.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.

Authors:  J H Atterhög; H Dunér; B Pernow
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

2.  The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels.

Authors:  S N Anavekar; W J Louis; T O Morgan; A E Doyle; C I Johnston
Journal:  Clin Exp Pharmacol Physiol       Date:  1975 May-Jun       Impact factor: 2.557

3.  Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.

Authors:  T L Svendsen; O Hartling; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

4.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

5.  Direct arterial pressure recording in unrestricted man.

Authors:  A T Bevan; A J Honour; F H Stott
Journal:  Clin Sci       Date:  1969-04       Impact factor: 6.124

6.  Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Eur Heart J       Date:  1983-07       Impact factor: 29.983

7.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 8.  Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

9.  Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.

Authors:  G Simon; J A Franciosa; H J Gimenez; J N Cohn
Journal:  Hypertension       Date:  1981 Mar-Apr       Impact factor: 10.190

10.  Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.

Authors:  H T Colfer; C Cottier; R Sanchez; S Julius
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

  10 in total
  1 in total

Review 1.  Is the ISA of pindolol beta 2-adrenoceptor selective?

Authors:  W H Aellig; B J Clark
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.